Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XI.ab

Gingival hypertrophy

Publications

Matsumura M, Suzuki Y, Yamagishi M, Kawano M

Nifedipine-induced gingival hypertrophy.

Internal medicine (Tokyo, Japan) 2012;51;121 — 2012 — 121

Naidoo LC, Stephen LX

Nifedipine-induced gingival hyperplasia: non-surgical management of a patient.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 1999 Jan-Feb;19;29-34 — 1999 Jan-Feb — 29-34